Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Ruosi Yao"'
Publikováno v:
Cell Communication and Signaling, Vol 20, Iss 1, Pp 1-16 (2022)
Abstract Background Transcription factor c-Myc plays a critical role in various physiological and pathological events. c-Myc gene rearrangement is closely associated with multiple myeloma (MM) progression and drug resistance. Thereby, targeting c-Myc
Externí odkaz:
https://doaj.org/article/dc7454bc490c4037b586b4f5fe7f1489
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Multiple myeloma (MM) is a malignant disease of plasma cells, which remains incurable because of its unclear mechanism and drug resistance. Herein, we aimed to explore new biomarkers and therapeutic targets in MM. After screening differentially expre
Externí odkaz:
https://doaj.org/article/6b1a530d523c49938f1a2a53d7d769d7
Autor:
Mingshan Niu, Yuan Feng, Ninghan Zhang, Tingting Shao, Huihui Zhang, Rong Wang, Yao Yao, Ruosi Yao, Qingyun Wu, Jiang Cao, Xuejiao Liu, Yubo Liu, Kailin Xu
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Acute myeloid leukemia (AML) pertains to a hematologic malignancy with heterogeneous therapeutic responses. Improvements in risk stratification in AML patients are warranted. MicroRNAs have been associated with the pathogenesis of
Externí odkaz:
https://doaj.org/article/ab22e7cfc56f454ea1b490160221ae9b
Publikováno v:
Molecules, Vol 23, Iss 5, p 1044 (2018)
Histone acetylation or deacetylation is closely associated with the progression of multiple myeloma (MM). Currently, many histone deacetylase (HDAC) inhibitors have been approved for being used in clinical trials, but theirtherapeutic effectsarestill
Externí odkaz:
https://doaj.org/article/5860b872f924459aa61e937b7ba89257
Autor:
Jieyun Xia, Hujun Li, Zhiling Yan, Dian Zhou, Ying Wang, Yuekun Qi, Jiang Cao, Depeng Li, Hai Cheng, Wei Sang, Feng Zhu, Haiying Sun, Wei Chen, Kunming Qi, Dongmei Yan, Tingting Qiu, Jianlin Qiao, Ruosi Yao, Yang Liu, Xue Wang, Yanlei Zhang, Shuixiu Peng, Chih-Hua Huang, Junnian Zheng, Zhenyu Li, Alex H. Chang, Kailin Xu
Publikováno v:
Journal of Clinical Oncology. 41:2583-2593
PURPOSE G protein–coupled receptor, class C group 5 member D (GPRC5D) is considered to be a promising surface target for multiple myeloma (MM) immunotherapy. Here, we report the efficacy and safety of anti-GPRC5D chimeric antigen receptor (CAR) T c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2dd577fa04c1322b3f5edb17dbcd147
https://doi.org/10.1200/jco.22.01824
https://doi.org/10.1200/jco.22.01824
Publikováno v:
Molecular and Cellular Biochemistry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba551c15212ebedeccbfc0ab2625df15
https://doi.org/10.1007/s11010-023-04764-6
https://doi.org/10.1007/s11010-023-04764-6
Autor:
Jun Lu, Baiqu Huang, Dong-Xu Liu, Yu Zhang, Guannan Wang, Li Zhao, Yanyan Gao, Pingfu Hou, Juan Du, Lin Wang, Liping Wang, Yuhui Ma, Hao Jiang, Ruosi Yao
PRMT7 induced an EMT program in other cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17dd05a732d5c2c752a001f000699379
https://doi.org/10.1158/0008-5472.22403001
https://doi.org/10.1158/0008-5472.22403001
Autor:
Jun Lu, Baiqu Huang, Dong-Xu Liu, Yu Zhang, Guannan Wang, Li Zhao, Yanyan Gao, Pingfu Hou, Juan Du, Lin Wang, Liping Wang, Yuhui Ma, Hao Jiang, Ruosi Yao
Expression of PRMT7 in clinical breast carcinoma samples
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024be297e178469bf890009f7d091231
https://doi.org/10.1158/0008-5472.22402968.v1
https://doi.org/10.1158/0008-5472.22402968.v1
Publikováno v:
Journal of Molecular Structure. 1275:134673
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f443a45a8adc578b1940d8273461f64
https://doi.org/10.1016/j.molstruc.2022.134673
https://doi.org/10.1016/j.molstruc.2022.134673
Autor:
Xiamin Wang, Guangyu Wei, Yangyang Ding, Xiang Gui, Huan Tong, Xiaoqi Xu, Sixuan Zhang, Zengtian Sun, Wen Ju, Yue Li, Ruosi Yao, Qingyu Wu, Zhihao Lu, Chunling Fu, Zhenyu Li, Si Zhang, Elizabeth E. Gardiner, Robert K. Andrews, Hu Hu, Lingyu Zeng, Kailin Xu, Jianlin Qiao
Publikováno v:
Blood. 140(9)
Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) is a protein tyrosine phosphatase that negatively regulates T-cell signaling. However, whether it is expressed and functions in platelets remains unknown. Here we investigated the expression a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efd3cc65df5e74e42e7aa9ea4839672b
https://pubmed.ncbi.nlm.nih.gov/36048474
https://pubmed.ncbi.nlm.nih.gov/36048474